Institutionelles- und Fonds-Eigentümerschaft - Käufer
Zu den wichtigsten Inhabern, die neue Positionen in SpyGlass Pharma, Inc. eröffnet haben, gehören Ra Capital Management, L.p., NEA Management Company, LLC, Sands Capital Ventures, LLC, Samsara BioCapital, LLC, Price T Rowe Associates Inc /md/, Vestal Point Capital, LP, Jpmorgan Chase & Co, Deerfield Management Company, L.p. (series C), Millennium Management Llc, Vanguard Capital Management Llc, First Light Asset Management, LLC, Franklin Resources Inc, Affinity Asset Advisors, LLC, Standard Life Aberdeen plc, BlackRock, Inc., Geode Capital Management, Llc, Monashee Investment Management LLC, Vanguard Fiduciary Trust Co, Charles Schwab Investment Management Inc, und Alyeska Investment Group, L.P. .
Diese Seite zeigt Veränderungen in der Eigentümerstruktur, indem sie Institutionen, Fonds und Großaktionäre auflistet, die im letzten Berichtszeitraum ihre Bestände erhöht oder neue Positionen eröffnet haben. Grüne Zeilen weisen auf neue Positionen hin. Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen.
Upgradezum Freischalten von Premium-Daten.
| Datei Datum | Quelle | Anleger | Typ | Durchschnittlicher Preis (Est) |
Aktien | Δ Aktien (%) |
Gemeldeter Wert ($1000) |
Δ Wert (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | 13F/A | Jpmorgan Chase & Co | 577.109 | 13.487 | ||||||
| 2026-05-15 | 13F | Millennium Management Llc | 468.794 | 12.146 | ||||||
| 2026-05-15 | 13F | Geode Capital Management, Llc | 126.540 | 3.281 | ||||||
| 2026-05-13 | 13F | Franklin Resources Inc | 300.000 | 7.773 | ||||||
| 2026-05-15 | 13F | First Light Asset Management, LLC | 375.000 | 9.716 | ||||||
| 2026-05-15 | 13F | Deerfield Management Company, L.p. (series C) | 550.000 | 14.250 | ||||||
| 2026-05-15 | 13F | Ra Capital Management, L.p. | 8.021.117 | 207.827 | ||||||
| 2026-05-14 | 13F | Marshall Wace, Llp | 29.348 | 760 | ||||||
| 2026-05-15 | 13F | Bank Of America Corp /de/ | 28.020 | 726 | ||||||
| 2026-05-15 | 13F | Vestal Point Capital, LP | 666.760 | 17.276 | ||||||
| 2026-05-15 | 13F | Manufacturers Life Insurance Company, The | 11.870 | 308 | ||||||
| 2026-05-15 | 13F | Royal Bank Of Canada | 85 | 2 | ||||||
| 2026-05-13 | 13F | Monashee Investment Management LLC | 95.000 | 2.461 | ||||||
| 2026-05-08 | 13F | Sands Capital Ventures, LLC | 2.500.012 | 64.775 | ||||||
| 2026-04-29 | 13F | Standard Life Aberdeen plc | 220.454 | 5.712 | ||||||
| 2026-05-05 | 13F | UBS Group AG | 455 | 12 | ||||||
| 2026-05-15 | 13F | NEA Management Company, LLC | 7.392.301 | 191.535 | ||||||
| 2026-05-14 | 13F | Affinity Asset Advisors, LLC | 250.000 | 6.478 | ||||||
| 2026-05-15 | 13F | Squarepoint Ops LLC | 7.811 | 202 | ||||||
| 2026-05-15 | 13F/A | Vanguard Capital Management Llc | 434.813 | 11.266 | ||||||
| 2026-05-15 | 13F | Charles Schwab Investment Management Inc | 59.610 | 1.544 | ||||||
| 2026-05-14 | 13F | Northern Trust Corp | 20.862 | 541 | ||||||
| 2026-05-15 | 13F | Goldman Sachs Group Inc | 19.283 | 500 | ||||||
| 2026-05-15 | 13F | Price T Rowe Associates Inc /md/ | 704.440 | 18 | ||||||
| 2026-05-13 | 13F | BlackRock, Inc. | 144.739 | 3.750 | ||||||
| 2026-05-15 | 13F | State Street Corp | 17.250 | 447 | ||||||
| 2026-05-08 | 13F | Vanguard Global Advisers, LLC | 4.927 | 128 | ||||||
| 2026-05-15 | 13F | Samsara BioCapital, LLC | 2.109.953 | 54.669 | ||||||
| 2026-05-08 | 13F | Vanguard Portfolio Management Llc | 3.680 | 95 | ||||||
| 2026-05-15 | 13F | Ameriprise Financial Inc | 44.477 | 1.152 | ||||||
| 2026-05-11 | 13F | Td Asset Management Inc | 47.580 | 1.233 | ||||||
| 2026-05-08 | 13F | Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 59.782 | 1.549 | ||||||
| 2026-05-15 | 13F | Alyeska Investment Group, L.P. | 57.000 | 1.477 | ||||||
| 2026-05-15 | 13F | Morgan Stanley | 4.179 | 108 |
